Skip to main content
INFU logo

InfuSystem Holdings, Inc.

INFUNYSEAMERICANHealthcareMedical Devices

$14.13Today:- (-)1Y +40.56%

As of Oct 27, 2026 close

Market cap
$295.60M
P/E (TTM)
34.60
Forward P/E
20.59
Dividend yield
-
52-week range
$7.29$14.27
Volume (live)
-
Avg. volume (3M)
132.31K

InfuSystem Holdings (INFU) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), InfuSystem Holdings generated $24.41M of operating cash flow and spent $8.69M on capital expenditures. That left free cash flow of $15.72M, up 498.7% from $2.63M a year earlier, or 11.0% of revenue. It repurchased $10.97M of its own shares.

InfuSystem Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for InfuSystem Holdings, Inc. (INFU) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income6.632.350.870.021.4217.331.36-1.10-20.71
Depreciation & Amortization13.2912.5012.5113.3614.6312.1312.3411.3112.52
Deferred Income Tax2.731.920.630.02-0.15-10.070.10-0.0615.39
Stock Based Compensation4.364.464.073.836.402.611.000.960.68
Change in Working Capital-0.090.65-5.560.39-2.69-1.27-0.19-4.95-5.38
Change in Accounts Receivable0.26-0.70-2.36-1.150.83-2.63-1.56-4.41-5.45
Change in Inventory1.14-0.13-1.58-0.88-0.86-0.10-0.65-0.490.40
Change in Accounts Payable-0.71-0.682.422.94-2.362.392.440.18-0.35
Change in Other Working Capital-0.792.160.12-0.52-0.29-0.93-0.42-0.230.02
Other Operating Activities0.220.500.12-0.09-1.44-10.07-0.745.235.07
Net Cash from Operating Activities24.4120.4611.2217.5218.3220.2813.8811.397.58
Investing Activities
Capital Expenditures-8.69-17.83-11.12-15.08-16.66-16.91-22.60-8.30-3.60
Acquisitions-1.410.000.003.60-7.984.752.953.323.87
Purchases of Investments0.000.000.00-14.090.000.000.000.000.00
Sales/Maturities of Investments0.000.000.0010.500.000.000.000.000.00
Other Investing Activities3.314.594.383.603.320.000.003.324.65
Net Cash from Investing Activities-6.79-13.24-6.73-11.48-21.32-12.16-19.64-4.981.05
Financing Activities
Debt Repayment-52.35-56.11-55.50-0.01-81.660.414.574.84-8.60
Common Stock Issued0.340.391.060.001.120.190.000.000.00
Common Stock Repurchased-10.97-2.00-1.31-6.65-1.73-1.71-0.72-10.47-0.06
Other Financing Activities-0.200.39-0.230.61-0.390.190.250.060.09
Net Cash from Financing Activities-14.96-6.92-4.42-6.06-6.46-1.124.10-5.56-8.57
Summary
Net Change in Cash2.660.300.07-0.02-9.467.00-1.670.850.07
Cash at Beginning of Period0.530.230.170.199.652.654.323.473.40
Cash at End of Period3.190.530.230.170.199.652.654.323.47
Free Cash Flow15.722.630.112.441.663.37-8.723.093.99
Supplemental Disclosures
Interest Paid-1.752.051.311.111.21---
Income Taxes Paid-0.750.210.150.170.10---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About InfuSystem Holdings Cash Flow

What is InfuSystem Holdings's free cash flow?

InfuSystem Holdings generated free cash flow of $15.72M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $24.41M minus $8.69M of capital expenditures. That was up 498.7% from $2.63M a year earlier. Free cash flow equaled 11.0% of revenue.

How much does InfuSystem Holdings spend on capital expenditures?

InfuSystem Holdings spent $8.69M on capital expenditures in fiscal 2025, compared with $17.83M a year earlier. That equals 35.6% of operating cash flow.

Does InfuSystem Holdings pay dividends or buy back shares?

Yes. In fiscal 2025 InfuSystem Holdings returned $10.97M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition